NASDAQ: CRSPCrispr Therapeutics Ag Stock Ownership - Who owns Crispr Therapeutics Ag?
Insider buying vs selling
Have Crispr Therapeutics Ag insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Samarth Kulkarni | Chief Executive Officer | 2024-04-15 | 1,204 | $60.40 | $72.72kSell |
| Samarth Kulkarni | Chief Executive Officer | 2024-04-15 | 19,582 | $19.12 | $374.41kBuy |
| Samarth Kulkarni | Chief Executive Officer | 2024-04-15 | 18,378 | $59.88 | $1.10MSell |
| Samarth Kulkarni | Chief Executive Officer | 2024-03-15 | 9,387 | $73.06 | $685.81kSell |
| Raju Prasad | Chief Financial Officer | 2024-03-15 | 3,524 | $72.69 | $256.16kSell |
| Samarth Kulkarni | Chief Executive Officer | 2024-03-15 | 20,000 | $19.12 | $382.40kBuy |
| Samarth Kulkarni | Chief Executive Officer | 2024-03-15 | 10,613 | $71.97 | $763.81kSell |
| Samarth Kulkarni | Chief Executive Officer | 2024-03-12 | 4,583 | $74.44 | $341.16kSell |
| James R. Kasinger | General Counsel and Secretary | 2024-03-12 | 1,146 | $74.44 | $85.31kSell |
| Samarth Kulkarni | Chief Executive Officer | 2024-03-11 | 9,802 | $78.26 | $767.10kSell |
CRSP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CRSP insiders and whales buy or sell their stock.
CRSP Shareholders
What type of owners hold Crispr Therapeutics Ag stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Celgene Corp | 10.66% | 8,557,514 | $459.80M | Insider |
| Ark Investment Management LLC | 10.63% | 8,536,104 | $458.64M | Institution |
| Capital International Investors | 7.64% | 6,134,450 | $329.60M | Institution |
| Vertex Pharmaceuticals Europe Ltd | 6.70% | 5,380,940 | $289.12M | Insider |
| Bayer Global Investments Bv | 6.36% | 5,105,330 | $274.31M | Insider |
| Simeon George | 5.32% | 4,269,578 | $229.40M | Insider |
| T Rowe Price Investment Management Inc | 4.50% | 3,611,186 | $194.03M | Institution |
| Nikko Asset Management Americas Inc | 4.20% | 3,369,762 | $181.06M | Institution |
| Sumitomo Mitsui Trust Holdings Inc | 4.20% | 3,369,762 | $181.06M | Institution |
| Glaxosmithkline PLC | 4.01% | 3,220,627 | $173.04M | Insider |
CRSP vs Biotech Stocks
Crispr Therapeutics Ag Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.